This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Botulinum neurotoxin
From Proteopedia
(Difference between revisions)
| Line 38: | Line 38: | ||
**[[2g7k]], [[2g7p]], [[2g7q]], [[2imc]], [[3bwi]], [[3bon]], [[3qix]], [[2ise]], [[2isg]], [[2ish]], [[4ej5]] - CbCBN LC + Zn<br /> | **[[2g7k]], [[2g7p]], [[2g7q]], [[2imc]], [[3bwi]], [[3bon]], [[3qix]], [[2ise]], [[2isg]], [[2ish]], [[4ej5]] - CbCBN LC + Zn<br /> | ||
| + | **[[5vgv]] - CbCBN LC + Cu<br /> | ||
| + | **[[5vgx]] - CbCBN LC + Hg<br /> | ||
**[[3bok]] - CbCBN LC <br /> | **[[3bok]] - CbCBN LC <br /> | ||
**[[1e1h]], [[1xtf]], [[4kuf]], [[4el4]], [[4elc]] - CbCBN LC (mutant) + Zn<br /> | **[[1e1h]], [[1xtf]], [[4kuf]], [[4el4]], [[4elc]] - CbCBN LC (mutant) + Zn<br /> | ||
| Line 44: | Line 46: | ||
**[[3dda]], [[3ddb]] - CbCBN LC + synaptosomal-associated protein 25 peptide + Zn<br /> | **[[3dda]], [[3ddb]] - CbCBN LC + synaptosomal-associated protein 25 peptide + Zn<br /> | ||
**[[3zur]], [[3zus]] - CbCBN LC/synaptosomal-associated protein 25 translocation domain<br /> | **[[3zur]], [[3zus]] - CbCBN LC/synaptosomal-associated protein 25 translocation domain<br /> | ||
| - | **[[2g7n]], [[2ilp]], [[2imb]], [[3qiy]], [[3qiz]], [[3qj0]], [[4hev]], [[2ima]] – CbCBN LC + inhibitor + Zn<br /> | + | **[[2g7n]], [[2ilp]], [[2imb]], [[3qiy]], [[3qiz]], [[3qj0]], [[4hev]], [[2ima]], [[5v8r]] – CbCBN LC + inhibitor + Zn<br /> |
**[[3c88]], [[3c89]], [[3c8a]], [[3c8b]], [[3boo]], [[3qw5]], [[3qw6]], [[3qw7]], [[3qw8]], [[3nf3]] – CbCBN LC + inhibitor peptide + Zn<br /> | **[[3c88]], [[3c89]], [[3c8a]], [[3c8b]], [[3boo]], [[3qw5]], [[3qw6]], [[3qw7]], [[3qw8]], [[3nf3]] – CbCBN LC + inhibitor peptide + Zn<br /> | ||
| - | **[[4ks6]], [[4ktx]] - CbCBN LC (mutant) + inhibitor peptide + Zn<br /> | + | **[[4ks6]], [[4ktx]], [[5v8p]], [[5v8u]] - CbCBN LC (mutant) + inhibitor peptide + Zn<br /> |
**[[3ds9]] – CbCBN LC (mutant) + inhibitor peptide + Zn + Ni<br /> | **[[3ds9]] – CbCBN LC (mutant) + inhibitor peptide + Zn + Ni<br /> | ||
**[[3k3q]] - CbCBN LC + antibody + Zn<br /> | **[[3k3q]] - CbCBN LC + antibody + Zn<br /> | ||
| Line 52: | Line 54: | ||
*Type A receptor-binding domain | *Type A receptor-binding domain | ||
| - | **[[2vua]], [[3fuo]], [[5tpb]], [[5tpc]] – CbPBN <br /> | + | **[[2vua]], [[3fuo]], [[5tpb]], [[5tpc]], [[5lr0]], [[5mk6]], [[5mk7]] – CbPBN <br /> |
**[[4iqp]] – CbPBN (mutant)<br /> | **[[4iqp]] – CbPBN (mutant)<br /> | ||
**[[2vu9]] – CbPBN + polysaccharide + Mg<br /> | **[[2vu9]] – CbPBN + polysaccharide + Mg<br /> | ||
| - | **[[4jra]], [[5jlv]] – CbCBN + synaptic vesicle glycoprotein 2C<br /> | + | **[[4jra]], [[5jlv]], [[5moy]] – CbCBN + synaptic vesicle glycoprotein 2C<br /> |
**[[5jmc]] – CbCBN (mutant) + synaptic vesicle glycoprotein 2C<br /> | **[[5jmc]] – CbCBN (mutant) + synaptic vesicle glycoprotein 2C<br /> | ||
**[[4zjx]] – CbCBN + polypeptide inhibitor<br /> | **[[4zjx]] – CbCBN + polypeptide inhibitor<br /> | ||
| + | **[[5l21]] – CbCBN + VHH-C2<br /> | ||
*Type A Light+Heavy Chain translocation domain | *Type A Light+Heavy Chain translocation domain | ||
| Line 83: | Line 86: | ||
**[[2nm1]], [[4kbb]] - CbCBN + synaptotagmin-2 peptide<br /> | **[[2nm1]], [[4kbb]] - CbCBN + synaptotagmin-2 peptide<br /> | ||
**[[1z0h]] – CbCBN <br /> | **[[1z0h]] – CbCBN <br /> | ||
| + | **[[5vid]] – CbCBN + mini-protein binder<br /> | ||
*Type C Light Chain | *Type C Light Chain | ||
| Line 133: | Line 137: | ||
**[[2vxr]], [[3mpp]] - CbCBN <br /> | **[[2vxr]], [[3mpp]] - CbCBN <br /> | ||
| + | |||
| + | *Type X Light Chain | ||
| + | |||
| + | **[[6f4e]] - CbCBN LC<br /> | ||
| + | **[[6f47]] - CbCBN LC + Zn<br /> | ||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 10:12, 2 April 2018
| |||||||||||
3D structures of botulinum neurotoxin
Updated on 02-April-2018
References
- ↑ Montecucco C, Molgo J. Botulinal neurotoxins: revival of an old killer. Curr Opin Pharmacol. 2005 Jun;5(3):274-9. PMID:15907915 doi:http://dx.doi.org/10.1016/j.coph.2004.12.006
- ↑ Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998 Oct;5(10):898-902. PMID:9783750 doi:10.1038/2338
